Acacia goes on patent-buying binge; MonoSol carries on with BioDelivery patent claim;

> Acacia Research Corp. ($ACTG) has purchased 13 patents for inhaler drug delivery technology from an unnamed company, the Newport Beach, CA Company has disclosed. Release

> MonoSol RX says it will continue to defend its patent claim against BioDelivery Sciences concerning the use of film drug delivery, despite a recent setback at the U.S. Patent Office. Release

> Discovery Laboratories said a recent clinical trial demonstrated its Afectair ventilator system delivered as much as 70% less nitric oxide to treat newborn infants with pulmonary hypertension compared to standard systems, while still reaching the target dose. Release

> Echo Therapeutics ($ECTE) has raised $5.4 million in direct equity financing. The Philadelphia company is developing the Prelude SkinPrep system for transdermal drug delivery of topical lidocaine and other drugs. Release

> Inovio Pharmaceuticals ($INO), a major of synthetic vaccines, raised a net of $3.7 million in an underwritten public offering to help fuel clinical trial and research expenses. Release

> Spectrum Pharmaceuticals ($SPPI) has filed an investigational new drug application with the FDA for SPI-014, a second-generation lanthanum-based nanoparticle phosphate binding agent designed to treat hyperphosphatemia in patients with end-stage renal disease. Release

> Aphios Corp. in Woburn has secured a U.S. patent involving a more organic way to formulate polymeric microspheres and nanospheres as components for a controlled-release, under the skin or oral delivery drug. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.